CIK 0001788028
- Non-accelerated filer
- Smaller reporting company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842984849
- Phone
- +1 650-549-1400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- 4 Shares withheld for taxes See Remarks gave up 37,126 shares (to pay taxes)
- 4 Open-market sale Director sold 8,500 shares at $1.44 ($12,240)
- 4 Open-market buy 10% owner bought 2,666,666 shares at $1.50 ($3,999,999)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 3,133,333 shares at $1.50 ($4,700,000)
- 4 Open-market sale 10% owner sold 75,000 shares at $1.89 ($141,750)
- 4 Grant or award President, CEO and Director acquired 506,250 shares (grant or award)
- 4 Grant or award Director acquired 24,500 shares (grant or award)
- 4 Grant or award Director acquired 30,250 shares (grant or award)
- 4 Grant or award Director acquired 29,500 shares (grant or award)
- 4 Grant or award See Remarks acquired 214,722 shares (grant or award)
- 4 Grant or award Director acquired 32,500 shares (grant or award)
- 4 Grant or award Director acquired 29,500 shares (grant or award)
- 4 Grant or award Director acquired 30,750 shares (grant or award)
Page 5 of 8 · 158 filings